Nintedanib esylate

Nintedanib esylate is an organosulfonate salt obtained by combining nintedanib with one molar equivalent of ethanesulfonic acid. A kinase inhibitor used for the treatment of idiopathic pulmonary fibrosis and cancer. Among its listed roles, it functions as a angiogenesis inhibitor, an antineoplastic agent, a fibroblast growth factor receptor antagonist, a tyrosine kinase inhibitor and a vascular endothelial growth factor receptor antagonist. It includes a nintedanib. It is grouped under the following drug class(es): Tyrosine Kinase Inhibitors and VEGF inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nintedanib ethanesulfonate and Nintedanib Ethanesulfonate Salt. Its PubChem CID is 135476717.

CAS No 656247-18-6
Molecular Formula C33H39N5O7S
Molecular Weight 649.8 g/mol
Synonyms ethanesulfonic acid;methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate

Frequently Asked Questions